• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估iPledge理解评估的可读性及其对异维A酸可及性的影响。

Evaluating the Readability of the iPledge Comprehension Assessment and its Impact on Isotretinoin Accessibility.

作者信息

Baek Peter, Shah Nidhi, Kirkorian A Yasmine

机构信息

The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Division of Dermatology, Children's National Hospital, Washington, DC, USA.

出版信息

Pediatr Dermatol. 2025 Mar-Apr;42(2):413-414. doi: 10.1111/pde.15765. Epub 2024 Sep 23.

DOI:10.1111/pde.15765
PMID:39308357
Abstract

Isotretinoin, the standard treatment for severe nodular acne, is subject to stringent iPLEDGE regulations due to its teratogenic risks, requiring monthly assessments for patients of childbearing potential. Analysis of the iPLEDGE Comprehension Assessment (iPCA) revealed an average readability score of grade 8.5, exceeding the recommended grade 6 level for optimal patient comprehension. The complex language of iPCA may hinder patients from accessing treatment, contributing to delays and potential discontinuation, especially among female patients. While the overall number of isotretinoin-exposed pregnancies has decreased since the inception of iPledge, several hundred pregnancies continue to be reported, and simplification of iPCA presents one avenue to improve patient comprehension, safety, and ensuring equitable access to isotretinoin.

摘要

异维A酸是重度结节性痤疮的标准治疗药物,因其致畸风险而受到严格的iPLEDGE法规监管,要求对有生育潜力的患者进行每月评估。对iPLEDGE理解评估(iPCA)的分析显示,平均可读性得分相当于八年级半的水平,超过了为实现最佳患者理解而建议的六年级水平。iPCA复杂的语言可能会阻碍患者接受治疗,导致治疗延误和潜在的停药情况,尤其是在女性患者中。虽然自iPledge实施以来,异维A酸暴露导致的妊娠总数有所下降,但仍有数百例妊娠报告,简化iPCA是提高患者理解度、安全性并确保公平获得异维A酸的一条途径。

相似文献

1
Evaluating the Readability of the iPledge Comprehension Assessment and its Impact on Isotretinoin Accessibility.评估iPledge理解评估的可读性及其对异维A酸可及性的影响。
Pediatr Dermatol. 2025 Mar-Apr;42(2):413-414. doi: 10.1111/pde.15765. Epub 2024 Sep 23.
2
Readability of iPledge materials for isotretinoin education in English and Spanish.英文和西班牙文版异维 A 酸教育用 iPledge 材料的可读性。
Arch Dermatol Res. 2023 Sep;315(7):2175-2178. doi: 10.1007/s00403-023-02598-2. Epub 2023 Mar 14.
3
Simplifying contraception requirements for iPLEDGE: A decision analysis.简化iPLEDGE的避孕要求:一项决策分析。
J Am Acad Dermatol. 2020 Jul;83(1):104-108. doi: 10.1016/j.jaad.2020.02.022. Epub 2020 Feb 14.
4
Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States.在美国,异维A酸与避孕药在iPledge前后的联合使用情况。
Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1251-7. doi: 10.1002/pds.3481. Epub 2013 Aug 3.
5
Contraceptive counseling for iPLEDGE and its burden on dermatologists.iPLEDGE 相关避孕咨询及其对皮肤科医生的负担。
Arch Dermatol Res. 2024 May 28;316(6):287. doi: 10.1007/s00403-024-03070-5.
6
Circumventing iPLEDGE: Circumventing ethical responsibility?规避iPLEDGE:规避道德责任?
J Am Acad Dermatol. 2017 Dec;77(6):1185-1187. doi: 10.1016/j.jaad.2017.06.156.
7
A comparative review of the isotretinoin pregnancy risk management programs across four continents.对四大洲异维 A 酸妊娠风险管理计划的比较评价。
Int J Dermatol. 2018 Sep;57(9):1035-1046. doi: 10.1111/ijd.13950. Epub 2018 Mar 6.
8
We Pledge to Change iPLEDGE.我们承诺改变“我承诺”计划。
JAMA Dermatol. 2015 Jul;151(7):701-2. doi: 10.1001/jamadermatol.2015.0736.
9
Can we ensure the safe use of known human teratogens?: The iPLEDGE test case.我们能否确保已知人类致畸剂的安全使用?:iPLEDGE案例分析。
Drug Saf. 2007;30(1):5-15. doi: 10.2165/00002018-200730010-00002.
10
A pox on your practice. iPLEDGE program scars dermatologists.你的行医行为遭天谴。iPLEDGE项目给皮肤科医生留下了创伤。
Tex Med. 2006 May;102(5):29-31.